Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | CFB | P00751 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6559883 | 1.00 | HDAC1 (0.37) | HDAC1HDAC8HDAC6CFBL3MBTL1 | |
| SCHEMBL23443025 | 0.77 | TACR1 (0.49) | HDAC1HDAC8HDAC6CFBTACR1 | |
| SCHEMBL19908470 | 0.77 | TACR1 (0.49) | HDAC1HDAC8HDAC6CFBTACR1 | |
| SCHEMBL28091456 | 0.76 | RORC (0.48) | L3MBTL1MAOBLTA4HRORC | |
| SCHEMBL20623694 | 0.74 | AKT1 (0.36) | HDAC1HDAC8HDAC6CFBL3MBTL1 | |
| SCHEMBL9044444 | 0.71 | CFB (0.35) | HDAC1HDAC8HDAC6CFBALDH1A1 | |
| SCHEMBL7759041 | 0.71 | CNR2 (0.49) | KMT2AMEN1 | |
| SCHEMBL6559879 | 0.71 | CNR2 (0.49) | KMT2AMEN1 | |
| SCHEMBL18482369 | 0.69 | CFB (0.35) | HDAC1HDAC8HDAC6CFBTACR1 | |
| SCHEMBL27367885 | 0.67 | ATR (0.40) | HDAC1HDAC8HDAC6KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1119358-A1 | USE OF AN NK-1 RECEPTOR ANTAGONIST FOR TREATING COGNITIVE DISORDERS | MERCK SHARP & DOHME LTD. (GB) | 2001-08-01 | — | — | EP | disclosed |
| EP-1087771-A1 | USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING BIPOLAR DISORDERS | MERCK SHARP & DOHME LTD. (GB) | 2001-04-04 | — | — | EP | disclosed |
| EP-1085875-A1 | USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING PSYCHIATRIC DISORDERS | MERCK SHARP & DOHME LTD. (GB) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999064009-A1 | USE OF AN NK-1 RECEPTOR ANTAGONIST FOR TREATING COGNITIVE DISORDERS | MERCK SHARP & DOHME LIMITED (GB) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999064010-A1 | USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING PSYCHIATRIC DISORDERS | MERCK SHARP & DOHME LIMITED (GB) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999064007-A1 | USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING BIPOLAR DISORDERS | MERCK SHARP & DOHME LIMITED (GB) | 1999-12-16 | — | — | WO | disclosed |